Declining China Dat...
Health Care: Drugs
ACADIA Pharmaceuticals Inc. (ACAD: NASDAQ)
$13.68 -0.11 | -0.82%
05/24/13 - 09:36 AM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 57.90M | 6.89M | 6.85M | 18.12M |
| Receivables | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 108.55M | 31.95M | 37.85M | 48.47M |
| Property, Plant & Equipment, Gross | 4.78M | 6.29M | 8.05M | 8.50M |
| Accumulated Depreciation & Depletion | 4.73M | 6.14M | 7.62M | 7.43M |
| Property, Plant & Equipment, Net | 42.00K | 151.00K | 426.00K | 1.06M |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 0.00 | 14.00K | 119.00K | 145.00K |
| Total Non-Current Assets | 42.00K | 165.00K | 545.00K | 1.21M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 108.59M | 32.11M | 38.39M | 49.68M |
| Accounts Payable | 1.38M | 1.96M | 1.97M | 2.95M |
| Short Term Debt | 0.00 | 32.00K | 78.00K | 365.00K |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 5.95M | 6.16M | 5.96M | 14.71M |
| Long Term Debt | 0.00 | 0.00 | 32.00K | 98.00K |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 17.66M | 2.59M | 2.72M | 22.76M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 17.66M | 2.59M | 2.75M | 22.86M |
| Total Liabilities | 23.61M | 8.75M | 8.71M | 37.57M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 84.98M | 23.36M | 29.69M | 12.11M |
| Common Par | 7.00K | 5.00K | 4.00K | 4.00K |
| Additional Paid In Capital | 452.69M | 370.22M | 353.28M | 350.87M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -367.72M | -346.87M | -324.11M | -339.24M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 4.00K | 9.00K | 512.00K | 483.00K |
| Total Capitalization | 84.98M | 23.36M | 29.72M | 12.21M |
| Total Equity | 84.98M | 23.36M | 29.69M | 12.11M |
| Total Liabilities & Stock Equity | 108.59M | 32.11M | 38.39M | 49.68M |
| Total Common Shares Outstanding | 73.33M | 52.90M | 39.35M | 38.33M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 55.12M | 52.18M | 38.59M | 37.48M |
| Diluted Weighted Shares Outstanding | 55.12M | 52.18M | 38.72M | 37.48M |
| Number of Employees | 26 | 24 | 27 | 27 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with ACAD
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserDividend Portfolio
- UserWatch
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Setting Up...
Latest ACAD Headlines from TheStreet
- ACADIA Stock Falls On Unusually High Volume (ACAD) 04.12.13 | 10:04 am
- Cramer's 6 Stocks in 60 Seconds: UA ADBE FTNT ACAD CELG RLGY (Update 1) 04.11.13 | 05:04 pm
- Stocks Ramp-Up on Encouraging Jobs Report 04.11.13 | 04:04 pm
- 5 Stocks Under $10 Set to Soar Higher 04.11.13 | 02:04 pm
- Acadia Plans Early FDA Filing Of Parkinson's Drug 04.11.13 | 07:04 am
- 'Mad Money' Lightning Round: Acadia Pharmaceuticals Is a Buy 04.05.13 | 06:04 am
- TheStreet Ratings Top 10 Rating Changes 04.01.13 | 11:04 am
- ACADIA Pharmaceuticals Inc. Stock Downgraded (ACAD) 03.28.13 | 05:03 am
- 'Mad Money' Lightning Round: Blackstone Is a Buy 03.23.13 | 06:03 am
- Cramer's 'Mad Money' Recap: Next Week's Game Plan 03.22.13 | 07:03 pm
Press Releases for ACAD
- Over $400 Million Raised By U.S. Life Sciences Companies Through At-the-Market (ATM) Offerings In 2012, Reports Brinson Patrick - PR Newswire 04.08.13 | 08:04 am
- ACADIA Announces Presentation Of Data From Its Pivotal Phase III Parkinson’s Disease Psychosis Study With Pimavanserin At The American Academy Of Neurology Annual Meeting - Business Wire 03.20.13 | 10:03 pm
- ACADIA Pharmaceuticals To Present At The 25th Annual ROTH Conference On March 19, 2013 - Business Wire 03.13.13 | 09:03 am
- ACADIA Pharmaceuticals Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2012 - Business Wire 03.12.13 | 04:03 pm
- ACADIA Pharmaceuticals To Announce Fourth Quarter And Full Year 2012 Financial Results On March 12, 2013 - Business Wire 03.05.13 | 09:03 am
- ACADIA Pharmaceuticals To Present At The Cowen And Company 33rd Annual Health Care Conference On March 4, 2013 - Business Wire 02.25.13 | 09:02 am
- ACADIA Pharmaceuticals To Present At The 15th Annual BIO CEO & Investor Conference On February 12, 2013 - Business Wire 02.05.13 | 09:02 am
- ACADIA Pharmaceuticals Announces Election Of Stephen R. Biggar To Its Board Of Directors - Business Wire 01.22.13 | 09:01 am
- ACADIA Pharmaceuticals To Receive Funding From Fast Forward And EMD Serono For Multiple Sclerosis Program - Business Wire 12.20.12 | 08:12 am
- ACADIA Pharmaceuticals To Present At The Oppenheimer 23rd Annual Healthcare Conference Today, December 12, 2012 - Business Wire 12.12.12 | 12:12 pm
Partner Headlines for ACAD
- U.S. Steel, Genomic Health and Other Stocks Insiders Are Buying - Benzinga 05.18.13 | 03:05 pm
- Pre-Market Most Active for May 15, 2013 : AINV, BAC, SPWR, SIRI, CVRR, BBRY, NOK, AMTD, SNE, RH, ACAD, TSLA - NASDAQ 05.15.13 | 12:05 pm
- Thursday's BioPharma Trade Movers - Seeking Alpha 04.18.13 | 09:04 am
- Pre-Market Most Active for Apr 11, 2013 : PCS, RAD, SGYP, INFI, MSFT, ACAD, RLGY, QQQ, FTNT, NOK, BAC, HPQ - NASDAQ 04.11.13 | 12:04 pm
- Moves in Smaller Health Care Stocks (ANAC, HALO, PBYI, QCOR) - Benzinga 03.23.13 | 11:03 am
- Mid-Day Market Update: Herman Miller Surges On Upbeat Earnings, Scholastic Falls - Benzinga 03.21.13 | 01:03 pm
- Pre-Market Most Active for Mar 21, 2013 : NOK, ORCL, SNY, BAC, BBRY, TOT, ACAD, CWT, CSCO, AWC, QQQ, ZNGA - NASDAQ 03.21.13 | 12:03 pm
- Acadia Forges Forward With Pimavanserin - Seeking Alpha 03.13.13 | 09:03 am
- After-Hours Earnings Report for March 12, 2013 : KW, DOLE, ACAD, GCA, GNMK, AVID, WSR, KTOS, GERN, ACRX, FOLD, GCAP - NASDAQ 03.12.13 | 06:03 pm
- Biotech Weekly Recap: Loads Of Bullishness, 2 Giant Rallies, And Selling - Seeking Alpha 12.02.12 | 09:12 am
